BioProcess International China Conference & Exhibition

Process Development and Manufacturing Strategies for Biotherapeutics throughout the Product Lifecycle

August 12-13, 2015 · Grand Hyatt Shanghai · Shanghai, China


Shengjiang Shawn Liu, Ph.D., Head and Principal Scientist, Pathogen Safety, Global Biologics Development, Bayer Healthcare Pharmaceuticals, USA

Scott Liu, President and CEO, Shanghai Henlius Biotech, China

H. Fai Poon, Ph.D., Director, Cell Culture, Hisun Pharmaceutical (Hangzhou) Co., Ltd., China

Scott M. Wheelwright, Ph.D., Founder and Principal Consultant, Complya Asia Co., Ltd., China

Chengbin Wu, Ph.D., President of R&D and Chief Scientific Officer, Shanghai CP Guojian Pharmaceutical Co., Ltd., China